How CAR-T Therapy, Known As A 'Living Drug,' May Help To Kill Forms Of Cancer

A new FDA-approved cell therapy holds promise for treating a form of blood cancer called multiple meyeloma . UT Southwestern Medical Center will soon begin clinical trials of CAR-T therapy to find out if it can succeed where older treatments have failed.